Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[The results of treating fibrous-cavernous tuberculosis in patients with different genetic markers].

Terapevticheskii arkhiv - 1 Jan 1990

Khomenko A G, Sadykov A S

Abstract excerpt

Overall 221 patients with fibrous-cavernous tuberculosis were examined. In patients carrying Hp 2-2 haptoglobin and HLA DR2, the disease runs an unfavourable course more frequently. Among the patients with Hp 2-2, the positive dynamics was attained by the 6th month of the treatment in 44.1%, among those with HLA DR2 in 42.3% of cases while in patients carrying the two genetic markers at a time, in only 32.4% of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antitubercular Agents
Share to Chronic Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Genetic Predisposition to Disease

Share to Haptoglobins

Share to HLA-DR Antigens

Share to Phenotype

Source

Identifiers

PMID: 2094991

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[The results of treating fibrous-cavernous tuberculosis in patients with different genetic markers].PMID 2094991Read ↗

[Course of infiltrating pulmonary tuberculosis depending on the patient's genotype].Semantic proximity Read ↗

[Results of the treatment of patients with recurrence of pulmonary tuberculosis with different types of haptoglobin].Semantic proximity Read ↗

[The role of genetically determined haptoglobin phenotypes in patients with destructive pulmonary tuberculosis].Semantic proximity Read ↗

[Genetic variants of haptoglobin in patients with destructive pulmonary tuberculosis].Semantic proximity Read ↗

[Prevention of adverse reactions of antituberculous drugs in pulmonary tuberculosis in patients with different genetic background].Semantic proximity Read ↗

[Prevention of adverse reactions of antituberculous drugs in pulmonary tuberculosis in patients with different genetic background].Semantic proximity Read ↗

[Indices of cell-mediated immunity in patients with pulmonary tuberculosis presenting with different haptoglobin phenotypes].Semantic proximity Read ↗

[Assessment of tuberculosis recurrence risk in phenotyping haptoglobin in patients with post-tuberculous residual changes in the lungs].Semantic proximity Read ↗

[Incidence and pattern of recurrent side effects in persons with different haptoglobin phenotypes during chemotherapy of pulmonary tuberculosis].Semantic proximity Read ↗

[Genetic variants of haptoglobin in patients with nephrotuberculosis].Semantic proximity Read ↗

[The nonspecific reactivity of patients with tuberculosis of the respiratory organs and different haptoglobin phenotypes].Semantic proximity Read ↗

[Immune status in patients with bone and joint tuberculosis and effect of HLA genotype].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.